NHC Comments on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses
The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Proposed Rule entitled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses” (the Proposed Rule).
Founded in 1920, the NHC is the only organization that brings together all segments of the health community to provide a united voice for the more than 160 million people with chronic diseases and disabilities and their family caregivers. Made up of more than 125 diverse national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient advocacy organizations, which control its governance and policy-making process. Other members include professional and membership associations; nonprofit organizations with an interest in health; and representatives from the pharmaceutical, generic drug, health insurance, device, and biotechnology industries.
As stated in our comments to CMS’ International Pricing model proposal, the NHC recognizes that the cost of treating and managing chronic conditions is significant and increasing. Five percent of the nation’s population drives nearly half of all health spending. We remain committed to supporting CMS in its efforts to reduce costs, promote high-value care, stimulate research and competition, and curb costs responsibly.